SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001104659-24-057003
Filing Date
2024-05-03
Accepted
2024-05-03 16:30:05
Documents
2
Period of Report
2024-04-30

Document Format Files

Seq Description Document Type Size
1 OWNERSHIP DOCUMENT tm2413417-1_3seq1.html 3  
1 OWNERSHIP DOCUMENT tm2413417-1_3seq1.xml 3 9035
2 EXHIBIT 24 tm2413417d1_ex24.htm EX-24 8158
  Complete submission text file 0001104659-24-057003.txt   18780
Mailing Address 16640 CHESTERFIELD GROVE ROAD SUITE 200 CHESTERFIELD MO 63005
Business Address BLOCK 10-1 BLANCHARDSTOWN CORPORATE PARK BALLYCOOLIN DUBLIN L2 15 636-449-1830
AVADEL PHARMACEUTICALS PLC (Issuer) CIK: 0001012477 (see all company filings)

IRS No.: 000000000 | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address AVADEL PHARMACEUTICALS PLC 10 EARLSFORT TERRACE DUBLIN L2 D02 T380
Business Address
Seurer Jerad G. (Reporting) CIK: 0002020970 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-37977 | Film No.: 24913629